metformin vs semaglutide for weight loss Ozempic Metformin: Understanding the Key Differences A chart compares 2 popular

In the United States, semaglutide isnt available as a generic drug

For the current FDA approval timeline, see our current FDA approval status

He stated, Semaglutide 2.4 mg not only reduces the first event risk but also lowers the cumulative cardiovascular burden making it a foundational therapy for secondary prevention in obesity-related cardiovascular disease Vince Lamanna, President of Novo Nordisk Canada, commented that these results expand the meaning of cardiovascular care by integrating obesity treatment as a proven strategy to prevent future events. He highlighted that Health Canadas decision to approve semaglutide 2.4 mg for patients with established CVD and overweight or obesity was the first global regulatory recognition of obesity therapy as a cardiovascular indication

Most people do gain their weight back-- not all of their weight